Tramadol Dosage and Renal Considerations

Dosage Modifications and Precautions

For patients with moderate renal impairment (GFR 30-60 mL/min), the American Journal of Kidney Diseases and the National Comprehensive Cancer Network recommend using tramadol with caution and considering dose reduction 1, 2
Patients at risk for AKI should have potentially nephrotoxic agents withdrawn before and after procedures involving contrast media, as recommended by the American Journal of Kidney Diseases 1
The American Journal of Kidney Diseases suggests temporarily suspending medications that affect renal function during intercurrent illness, planned IV radiocontrast administration, or prior to major surgery 1
Avoid concomitant use of other nephrotoxic agents when possible in patients with or at risk for AKI, as recommended by the American Journal of Kidney Diseases 1

Tramadol should be used with caution or avoided in patients taking serotonergic medications (SSRIs, TCAs, MAOIs) due to risk of serotonin syndrome, according to the National Comprehensive Cancer Network 3, 2
The National Comprehensive Cancer Network recommends lower doses for patients with hepatic dysfunction to reduce risk of seizures 2
Tramadol is considered approximately one-tenth as potent as morphine, with a maximum recommended daily dose of 400 mg in patients with normal renal function, as stated by the National Comprehensive Cancer Network 2
Monitor for signs of opioid toxicity including respiratory depression, excessive sedation, and confusion, which may occur at lower doses in patients with renal impairment, as recommended by the National Comprehensive Cancer Network 2
Consider measuring GFR 48-96 hours after procedures involving contrast media in patients receiving tramadol who are at risk for AKI, as suggested by the American Journal of Kidney Diseases 1